Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Oct 3, 2022--
The "Dry Eye Syndrome Therapeutics Market Analysis by Product Type, by Disease Type, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The dry eye syndrome (DES) therapeutics market size is estimated to be USD 4,310 million in 2021 and is expected to witness a CAGR of 9.45% during the forecast period 2022-2029.
The growing number of persons who get dry eyes, increasing healthcare costs, and a rise in the volume of R&D activity are some of the primary market drivers.
However, the significant financial burden of therapy, a scarcity of competent personnel, and a lack of healthcare facilities in emerging economies, restrictive drug approval procedures used by testing organizations cause the launch of new medications to be delayed are expected to restrain the market growth.
This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product type, and disease type from 2022-2029.
Segmentation:
Dry Eye Syndrome (DES) Therapeutics Market Analysis Report 2021-2029
Product Type (Revenue, USD Million)
Disease Type (Revenue, USD Million)
By Region (Revenue, USD Million)
North AmericaCompanies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/dmiqt9
View source version on businesswire.com:https://www.businesswire.com/news/home/20221003005628/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH OPTICAL
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 10/03/2022 09:26 AM/DISC: 10/03/2022 09:26 AM
http://www.businesswire.com/news/home/20221003005628/en